The recently opened trial is hoped to improve outcomes, transform treatments and save lives of Ewing Sarcoma patients. Although Ewing Sarcoma can be diagnosed at any age, it occurs most frequently in ...
Due to the relatively inferior long-term patient outcomes, we recognize the need for improving our understanding of pediatric sarcomas, specifically osteosarcoma, Ewing sarcoma and rhabdomyosarcoma.
a novel GSK-3β inhibitor for treatment of Ewing sarcoma (EWS). “Receiving rare pediatric disease designation from the FDA underscores the urgent need for new treatment options for patients with ...